glp 1 protein GLP-1 receptor biology: structure, signaling, and distribution Structure of Semaglutide-bound Glucagon-Like Peptide-1

GLP-1 Agonists in Type 2 Diabetes Management Managing type 2 diabetes is often complex, involving lifestyle changes, blood sugar monitoring, and medications

In a retrospective cohort study including 7,044 patients with T2D, obesity (BMI 27 kg/m 2 ) and HFpEF, combination therapy with an SGLT2i and GLP-1 RA showed a lower risk of HF exacerbation, all-cause emergency department visits and new-onset kidney injury compared with patients only receiving SGLT2i

2019;55(6):p

The data suggest theres still headroom for efficacy within existing molecules

While all medications carry some risk of side effects, GLP-1s tend to have a favorable side effect profile, especially when compared to other weight-loss medications

Adding maintenance time pushes total treatment to 12 to 18 months minimum for significant weight loss goals